← Back to patent-cliff list
CAS 110-91-8
morpholineDiethylene oximide1-Oxa-4-azacyclohexane
Codes: APIX-012, CARF-022, PEMIGA-027, SOTA-004, COBI-025, Timolol Maleate-007, IXAB-012, (IV) 920279-1-a, (III) 920279-2-a, (II) 920279-3-a, LINE-002, CELE-008
Application context (from source-drug indications)
Pulmonary embolismApixabanVenous thrombosisApixabanPaget-Schroetter syndromeApixabanVenous thromboembolismApixabanThrombosisApixabanEmbolismApixabanMultiple myelomaCarfilzomibMyelomaPemigatinibLymphomaPemigatinibBile duct cancerPemigatinibCholangiocarcinomaPemigatinibBiliary tract cancerPemigatinibType 2 diabetesSotagliflozinChronic renal impairmentSotagliflozinHeart failureSotagliflozinHIV infectionCobicistatNon-small cell lung cancerCobicistatAcquired immunodeficiency syndromeCobicistatOcular hypertensionBrimonidine Tartrate/Timolol MaleateGlaucomaBrimonidine Tartrate/Timolol MaleateBreast cancerIxabepiloneMetastatic breast cancerIxabepiloneCervical cancerIxabepiloneProstate cancerIxabepiloneSolid tumourIxabepiloneNeutropeniaIxabepiloneOcular hypertensionBimatoprost/Timolol MaleateOpen-angle glaucomaBimatoprost/Timolol MaleateGlaucomaBimatoprost/Timolol MaleateOcular hypertensionTimolol MaleateGlaucomaTimolol MaleateOpen-angle glaucomaTimolol MaleateTrauma and injuryTimolol MaleateHypertensionTimolol MaleateMigraineTimolol MaleateNon-small cell lung cancerLazertinib MesylateHepatic function declineLazertinib Mesylate非复杂性皮肤和皮肤结构感染LinezolidPneumoniaLinezolidComplicated skin and skin structure infectionLinezolidBacteraemiaLinezolidBacterial infectionLinezolidHealthcare-associated pneumoniaLinezolidPainCelecoxibInflammatory diseaseCelecoxib关节周围炎Celecoxib肌腱炎Celecoxib颈肩腕综合征CelecoxibLow back painCelecoxib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Apixaban | Tier A — Act now | 2028 |
| Carfilzomib | Tier B — Position early | 2029 |
| Pemigatinib | Tier C — Watch / trade | 2032 |
| Sotagliflozin | Tier C — Watch / trade | 2032 |
| Cobicistat | Tier C — Watch / trade | - |
| Brimonidine Tartrate/Timolol Maleate | Tier C — Watch / trade | - |
| Ixabepilone | Tier C — Watch / trade | - |
| Bimatoprost/Timolol Maleate | Tier C — Watch / trade | - |
| Timolol Maleate | Tier C — Watch / trade | - |
| Lazertinib Mesylate | Tier C — Watch / trade | - |
| Linezolid | Tier B — Position early | - |
| Celecoxib | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(4-iodophenyl)piperidin-2-one→ethyl (Z)-2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate→piperidin-2-one→3,3-dichloropiperidin-2-one→3-chloro-5,6-dihydropyridin-2(1H)-one→morpholine→3-morpholino-5,6-dihydropyridin-2(1H)-one→ethyl 1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate→1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid
4-iodoaniline→1-(4-iodophenyl)piperidin-2-one→3,3-dichloro-1-(4-iodophenyl)piperidin-2-one→1-(4-iodophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one→ethyl (Z)-2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate→piperidin-2-one→ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate→morpholine→5-bromopentanoic acid→5-bromo-N-(4-iodophenyl)pentanamide→3-chloro-1-(4-iodophenyl)-5,6-dihydropyridin-2(1H)-one→3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
(tert-butoxycarbonyl)-L-leucine→(S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoic acid→((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalanine→(S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-aminium 2,2,2-trifluoroacetate→tert-butyl (S)-(1-(methoxy(methyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate→tert-butyl (S)-(2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate→tert-butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate→(S)-methyl 2-amino-3-phenylpropanoate→methyl (tert-butoxycarbonyl)-L-leucyl-L-phenylalaninate→(S)-1-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-methyl-1-oxopentan-2-aminium 2,2,2-trifluoroacetate→methyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate→2-chloroacetyl chloride→methyl ((S)-2-(2-chloroacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate→morpholine→methyl ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate→N,O-dimethylhydroxylamine hydrochloride→prop-1-en-2-ylmagnesium bromide
4-chloro-1H-pyrrolo[2,3-b]pyridine→4-chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine→4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde→4-(ethylamino)-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde→2,6-difluoro-3,5-dimethoxyaniline→5-(((2,6-difluoro-3,5-dimethoxyphenyl)amino)methyl)-N-ethyl-1H-pyrrolo[2,3-b]pyridin-4-amine→3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one→3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-7-(phenylsulfonyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one→3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-2-oxo-7-(phenylsulfonyl)-2,3,4,7-tetrahydro-1H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidine-8-carbaldehyde→morpholine→3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-7-(phenylsulfonyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one→Pemigatinib
(3S,4R,5S)-tetrahydro-2H-pyran-2,3,4,5-tetraol→(3aS,5S,6R,6aS)-5-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol→(3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid→morpholine→((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone→1-chloro-2-(4-ethoxybenzyl)-4-iodobenzene→(4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone→(2S,3S,4R,5R,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetraol→(2R,3S,4R,5S,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate→(2S,3S,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate→2-chloro-5-iodobenzoic acid→2-chloro-5-iodobenzoyl chloride→ethoxybenzene→(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
1-(2-isopropylthiazol-4-yl)-N-methylmethanamine→thiazol-5-ylmethyl ((2R,5R)-5-amino-1,6-diphenylhexan-2-yl)carbamate→(2R,5R)-1,6-diphenylhexane-2,5-diamine→4-nitrophenyl (thiazol-5-ylmethyl) carbonate→(S)-benzyl (1-hydroxy-3-phenylpropan-2-yl)carbamate→dibenzyl ((2S,3R,4R,5S)-3,4-dihydroxy-1,6-diphenylhexane-2,5-diyl)dicarbamate→di(1H-imidazol-1-yl)methanethione→dibenzyl ((1S,1'S)-((4R,5R)-2-thioxo-1,3-dioxolane-4,5-diyl)bis(2-phenylethane-1,1-diyl))dicarbamate→dibenzyl ((2S,5S,E)-1,6-diphenylhex-3-ene-2,5-diyl)dicarbamate→(S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoic acid→(S)-3-aminodihydrofuran-2(3H)-one hydrobromide→(S)-1-((2-isopropylthiazol-4-yl)methyl)-1-methyl-3-(2-oxotetrahydrofuran-3-yl)urea→(S)-benzyl 4-hydroxy-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)butanoate→(S)-benzyl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-oxobutanoate→morpholine→(S)-benzyl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate
1-(2-isopropylthiazol-4-yl)-N-methylmethanamine→(2R,5R)-1,6-diphenylhexane-2,5-diamine→4-nitrophenyl (thiazol-5-ylmethyl) carbonate→(S)-3-aminodihydrofuran-2(3H)-one hydrobromide→(S)-1-((2-isopropylthiazol-4-yl)methyl)-1-methyl-3-(2-oxotetrahydrofuran-3-yl)urea→morpholine→(S)-2-benzylaziridine→dimethylsulfamoyl chloride→(S)-2-benzyl-N,N-dimethylaziridine-1-sulfonamide→COBI-030→(2S,5S,E)-1,6-diphenylhex-3-ene-2,5-diamine→(2R,5R)-1,6-diphenylhexane-2,5-diamine dihydrochloride→thiazol-5-ylmethyl ((2R,5R)-5-amino-1,6-diphenylhexan-2-yl)carbamate hydrochloride→potassium (S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate→(S)-2-amino-4-(methylthio)butanoic acid→(S)-ethyl 4-iodo-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)butanoate→(S)-ethyl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate oxalate
Brimonidine Tartrate/Timolol MaleateOptimised routesteps: 5total yield: 108.7g(Timolol Maleate (API))
4-(4-Morpholinyl)-1,2,5-thiadiazol-3-ol→(+/-)-2-(Chloromethyl)oxirane→2-Methylpropan-2-amine→1-(tert-Butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol→(S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol→3,4-Dichloro-1,2,5-thiadiazole→Diethylene oximide→4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine→[(5S)-3-tert-Butyl-1,3-oxazolidin-5-yl]methanol
N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpropionamide→5-bromopent-1-ene→(S)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N,2-dimethylhept-6-enamide→(1S,2S)-1-(((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)(methyl)amino)-2-methylhept-6-en-1-ol→(S)-2-methylhept-6-enal→3-((tert-butyldimethylsilyl)oxy)-4,4-dimethyl-5-oxoheptanoic acid→(3S,6R,7S,8S)-3-((tert-butyldimethylsilyl)oxy)-7-hydroxy-4,4,6,8-tetramethyl-5-oxotridec-12-enoic acid→(S,1E,5E)-2-methyl-1-(2-methylthiazol-4-yl)hepta-1,5-dien-3-amine→(3S,6R,7S,8S)-3-((tert-butyldimethylsilyl)oxy)-7-hydroxy-4,4,6,8-tetramethyl-N-((S,1E,5E)-2-methyl-1-(2-methylthiazol-4-yl)hepta-1,5-dien-3-yl)-5-oxotridec-12-enamide→(4S,7R,8S,9S,16S,Z)-4-((tert-butyldimethylsilyl)oxy)-8-hydroxy-5,5,7,9,13-pentamethyl-16-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)azacyclohexadec-13-ene-2,6-dione→(4S,7R,8S,9S,16S,Z)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)azacyclohexadec-13-ene-2,6-dione→morpholine→isobutyraldehyde→4-(2-methylprop-1-en-1-yl)morpholine→(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl pentanoate→2,2-dimethyl-3-oxopentanal→allylbis(4,6,6-trimethylbicyclo[3.1.1]hept-2-en-3-yl)borane→tert-butyldimethylsilyl trifluoromethanesulfonate→5-((tert-butyldimethylsilyl)oxy)-4,4-dimethyloct-7-en-3-one→3-((tert-butyldimethylsilyl)oxy)-4,4-dimethyl-5-oxoheptanal→(S,E)-2-aminopent-3-enoic acid→(S,E)-2-((tert-butoxycarbonyl)amino)pent-3-enoic acid→tert-butyl (S,E)-(1-(methoxy(methyl)amino)-1-oxopent-3-en-2-yl)carbamate→tert-butyl (S,E)-(2-oxohept-5-en-3-yl)carbamate→((2-methylthiazol-4-yl)methyl)diphenylphosphine oxide→tert-butyl ((S,1E,5E)-2-methyl-1-(2-methylthiazol-4-yl)hepta-1,5-dien-3-yl)carbamate→methoxybis(4,6,6-trimethylbicyclo[3.1.1]hept-2-en-3-yl)borane
4-(4-Morpholinyl)-1,2,5-thiadiazol-3-ol→(+/-)-2-(Chloromethyl)oxirane→2-Methylpropan-2-amine→1-(tert-Butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol→(S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol→3,4-Dichloro-1,2,5-thiadiazole→Diethylene oximide→4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine→[(5S)-3-tert-Butyl-1,3-oxazolidin-5-yl]methanol
4-(4-Morpholinyl)-1,2,5-thiadiazol-3-ol→(+/-)-2-(Chloromethyl)oxirane→2-Methylpropan-2-amine→1-(tert-Butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol→(S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol→3,4-Dichloro-1,2,5-thiadiazole→Diethylene oximide→4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine→[(5S)-3-tert-Butyl-1,3-oxazolidin-5-yl]methanol
2-Amino-5-fluoro-4-nitroanisole→1-(2-Iodopyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde→1-[2-(4-Fluoro-2-methoxy-5-nitroanilino)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→1-Oxa-4-azacyclohexane→1-[2-[2-Methoxy-4-(morpholin-4-yl)-5-nitroanilino]pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→Dimethylamine anhydrous→4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine→N1-[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]-6-methoxy-4-(morpholin-4-yl)benzene-1,3-diamine→2-Propenoyl chloride; Acrylic acid chloride; Acrylic chloride; Acryloyl chloride→N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide
2-Amino-5-fluoro-4-nitroanisole→N-Boc-4-Fluoro-2-methoxy-5-nitroaniline→1-Oxa-4-azacyclohexane→N-Boc-2-Methoxy-4-morpholin-4-yl-5-nitroaniline→tert-Butyl [5-amino-2-methoxy-4-(morpholin-4-yl)phenyl]carbamate→(Chloromethyl)acetyl chloride→tert-Butyl [5-(3-chloropropanamido)-2-methoxy-4-(morpholin-4-yl)phenyl]carbamate→N-(5-N-Boc-Amino-4-methoxy-2-morpholin-4-ylphenyl)acrylamide→N-[5-Amino-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→1-(2-Chloropyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde→N-[5-[[4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→Dimethylamine hydrochloride→N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide
2-Amino-5-fluoro-4-nitroanisole→1-Oxa-4-azacyclohexane→2-Methoxy-4-(morpholin-4-yl)-5-nitroaniline→2-Methoxy-4-morpholin-4-yl-5-nitrophenylformamide→5-Amino-2-methoxy-4-morpholin-4-ylphenylformamide→(Chloromethyl)acetyl chloride→3-Chloro-N-[5-formamido-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide→N-[5-(Formylamino)-4-methoxy-2-morpholin-4-ylphenyl]acrylamide→1-[2-(Methanesulfonyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→N-[5-[[4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→Dimethylamine hydrochloride→N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→3-Phenyl-1H-pyrazole-4-carbaldehyde→4-Chloro-2-(methylsulfanyl)pyrimidine→1-[2-(Methylsulfanyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde
1,2-difluoro-4-nitrobenzene→morpholine→4-(2-fluoro-4-nitrophenyl)morpholine→3-fluoro-4-morpholinoaniline→benzyl (3-fluoro-4-morpholinophenyl)carbamatebenzyl (3-fluoro-4-morpholinophenyl)carbamate→(R)-oxiran-2-ylmethyl butyrate→(R)-3-(3-fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one→(R)-(3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate→(R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
1,2-difluoro-4-nitrobenzene→morpholine→4-(2-fluoro-4-nitrophenyl)morpholine→3-fluoro-4-morpholinoaniline→(R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one→4-(2-fluoro-4-isocyanatophenyl)morpholine→(R)-2-(chloromethyl)oxirane→(R)-5-(chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 3-Morpholino-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin.2(1H)-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 1-(4-Methoxyphenyl)-7-0xo-6-[4-(2-0xopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acidethyl ester Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | CarbaMic acid, N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 1-Pentanone, 2-aMino-4-Methyl-1-[(2R)-2-Methyloxiranyl]-, (2S)-, trifluoroacetate (9CI) Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | (alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | (alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate) Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | (alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine methyl ester Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 3-phenyl-1H-pyrazole-4-carbaldehyde Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 4-Chloro-2-(methylsulfonyl)pyrimidine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 4-chloro-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 1-(2-((2-methoxy-4-morpholino-5-nitrophenyl)amino)pyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | N1-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)-6-methoxy-4-morpholinobenzene-1,3-diamine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | L-xylose Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-4,5-O-(1-Methylethylidene)-,(5S)- Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | ((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.